Common use of IRO Initial Report Clause in Contracts

IRO Initial Report. By March 1, 2013, GSK shall submit to OIG a report with respect to the status of, and findings regarding, the IRO Reviews for the first IRO Reporting Period (IRO Initial Report). 1. a complete copy of all reports prepared pursuant to Section III.E, and Appendix B along with a copy of the IRO’s engagement letters; 2. GSK’s response to the reports prepared pursuant to the reviews outlined in Section III.E and Appendix B, along with corrective action plan(s) related to any issues raised by the reports; GlaxoSmithKline LLC Corporate Integrity Agreement 3. a summary and description of any and all current and prior engagements and agreements between GSK and the IRO (if different from what was submitted as part of the Implementation Report); 4. certifications from the IRO regarding its professional independence and objectivity with respect to GSK;